March 4, 2024 06:30 AM EST
Financing
Startups

Ex­clu­sive: No­cion rais­es $62M for dif­fer­ent ap­proach to chron­ic cough than Mer­ck, GSK

Kyle LaHucik

Senior Reporter

In the mid­dle of 2023, Richard Baty­cky told a cou­ple of his fel­low ex­ec­u­tives at No­cion Ther­a­peu­tics to con­sid­er look­ing for roles else­where. He wasn’ …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

No­vo and Viking present new MASH da­ta, but an­a­lysts re­main con­fi­dent in Madri­gal's Rezd­if­fra

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times